COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL DISEASES Russian patent published in 2019 - IPC C07D217/04 A61P9/04 A61P9/12 A61P31/12 

Abstract RU 2684097 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to medicine, specifically to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart failure, in particular congestive heart failure, chronic kidney disease, advanced stage kidney disease, liver disease, and fluid retention caused by a peroxisome proliferator-activated gamma receptor agonist (PPAR). Invention also relates to compounds and methods for the treatment of hypertension, for the treatment of diseases of the gastrointestinal tract, including the treatment or reduction of pain associated with gastrointestinal diseases.

EFFECT: compounds are not absorbed and are not systemically bioavailable.

11 cl, 9 tbl, 79 ex

Similar patents RU2684097C2

Title Year Author Number
PHENYLTETRAHYDROISOQUINOLINE COMPOUND, SUBSTITUTED WITH HETEROARYL 2015
  • Kuroda, Shoichi
  • Kawabe, Kenichi
  • Ushiki, Yasunobu
  • Ohta, Hiroshi
  • Uneuchi, Fumito
  • Shibata, Tsuyoshi
  • Tabuse, Hideaki
  • Munemoto, Eiji
  • Chonan, Sumi
RU2703456C2
DERIVATIVES OF TETRAHYDROISOQUINOLINE, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR INHIBITION OF SYNAPTIC UPTAKE OF DOPAMINE AND TREATMENT METHOD 2000
  • Bek Dzhejms P.
  • Smit Mark A.
RU2293728C2
SUBSTITUTED 4-PHENYLTETRAHYDROISOQUINOLINES, PREPARATION METHOD, APPLICATION AS MEDICINAL AGENTS, AND ALSO MEDICINAL AGENTS CONTAINING THEM 2005
  • Khajnel'T Uve
  • Lang Khans-Jokhen
  • Virt Klaus
  • Likher Tomas
  • Khofmajster Armin
RU2398766C2
NOVEL HETEROCYCLIC DERIVATIVES AND THEIR MEDICINAL USING 2002
  • Matsui Khirosi
  • Kobajasi Khideo
  • Azukizava Satoru
  • Kasaj Masajasu
  • Josimi Akikhisa
  • Sirakhase Khiroaki
RU2287529C2
SUBSTITUTED 4-PHENYLTETRAHYDROISOQUINOLINES, METHOD OF THEIR OBTAINING, THEIR APPLICATION AS MEDICATIONS, AND MEDICATIONS CONTAINING THEM 2004
  • Khofmajster Armin
  • Khajnel'T Uve
  • Lang Khans-Jokhen
  • Frik Vendelin
  • Bljajkh Markus
  • Virt Klaus
RU2343147C2
SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVE AS POSITIVE ALLOSTERIC MODULATOR D1 2020
  • Ates Ali
  • Skolc David
RU2824581C2
DERIVATIVES OF 4-HYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE-1-YL-UREA AND THEIR USE IN TREATMENT, INTER ALIA, DISEASES OF RESPIRATORY TRACT 2011
  • Finch Harry
  • Van Niel Monique Bodil
  • Woo Chi-Kit
RU2586333C1
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION BASED ON SAID, METHOD OF PATIENT TREATMENT, INTERMEDIATE COMPOUND 1993
  • Dzhen M.Brajt
  • Uillard M.Uehlch
RU2130453C1
DERIVATIVES OF TETRAHYDROISOQUINOLINE AND THEIR SALTS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 2000
  • Matsui Khirosi
  • Kobajasi Khideo
  • Azukizava Satoru
  • Kasai Masajasu
  • Josimi Akikhisa
  • Sirakhase Khiroaki
RU2256661C2
KINASE INHIBITORS 2012
  • Van Niel Monique Bodil
  • Ray Nicholas Charles
  • Alcaraz Lilian
  • Panchal Terry Aaron
  • Jennings Andrew Stephen Robert
  • Armani Elisabetta
  • Cridland Andrew Peter
  • Hurley Christopher
RU2623734C9

RU 2 684 097 C2

Authors

Bell Noah

Carreras Christopher

Charmot Dominique

Chen Tao

Leadbetter Michael

Jacobs Jeffrey

Lewis Jason

Dates

2019-04-04Published

2013-08-20Filed